Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,630.00
Bid: 2,630.00
Ask: 2,635.00
Change: 0.00 (0.00%)
Spread: 5.00 (0.19%)
Open: 2,620.00
High: 2,640.00
Low: 2,620.00
Prev. Close: 2,630.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Steve Crummett as Finance Director

10 Jan 2013 07:00

RNS Number : 2188V
Morgan Sindall Group PLC
10 January 2013
 



 

10 January 2013

 

Morgan Sindall Group plc: Appointment of Steve Crummett as Finance Director

 

The Board of Morgan Sindall Group plc ('Morgan Sindall' or the 'Group') today announces the appointment of Steve Crummett as Finance Director with effect from 25 February 2013. Current Finance Director, David Mulligan, has indicated that, after fifteen years with the Group, he would like to step down from his current role to pursue new challenges and, with the appointment of Steve Crummett, he will be leaving the Group on 10 April 2013 following a handover period.

 

Steve Crummett was most recently the Group Finance Director at Filtrona plc, a position he held from 2008. Prior to Filtrona, Steve held senior positions in a number of listed companies including Exel plc, Mckechnie plc and Logica plc. He qualified as a Chartered Accountant with Arthur Andersen. Steve is also a Non-Executive Director of Consort Medical plc.

 

Chairman, Adrian Martin, said:

 

'On behalf of the Board I would like to thank David Mulligan for his significant contribution and commitment to Morgan Sindall over the past fifteen years. In his time with us, David has been instrumental in developing strong reporting disciplines and controls and has been a collaborative and supportive member of the team.

 

I am delighted that we have recruited a person of Steve Crummett's calibre as Finance Director. He has gained substantial and wide-ranging experience across a number of businesses and has valuable and significant skills which are relevant to Morgan Sindall as the business continues to focus on growth opportunities for the medium to longer-term.'

 

 

 

-Ends -

 

There are no further details to be disclosed pursuant to Listing Rule 9.6.13 in connection with Mr Crummett's appointment.

 

 

Morgan Sindall Group plc Tel: 020 7307 9200

Adrian Martin, Chairman

John Morgan, Chief Executive

 

Brunswick Tel: 0207 404 5959

Jonathan Glass

Nick Cosgrove

 

Notes to Editors:

 

Biography of Steve Crummett

 

From March 2008 to September 2012, Steve was the Group Finance Director of Filtrona plc, the FTSE 250 leading supplier of specialty plastic, fibre and foam products and was responsible for Finance, Tax, Treasury, IT, Internal Audit and Risk. From May 2007 to March 2008 he was Director of Corporate Development at Filtrona. Prior to Filtrona, Steve was at Exel plc from 2003 to 2006, through its acquisition by Deutsche Post. From 1997 to 2002, Steve was Head of Corporate Development at McKechnie plc, and Corporate Finance Manager at Logica plc from 1995 to 1997. He qualified as a Chartered Accountant with Arthur Andersen.

 

Morgan Sindall Group plc is a leading UK construction and regeneration group with a turnover of £2 billion, employing around 7,000 employees and operating in the public and commercial sectors. It operates through five divisions of construction and infrastructure, affordable housing, fit out, urban regeneration and investments.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADMGGMLLVGFZM
Date   Source Headline
2nd Sep 20192:49 pmRNSTotal Voting Rights
13th Aug 20193:34 pmRNSHolding(s) in Company
7th Aug 20197:00 amRNSHalf-year Report
1st Aug 201910:08 amRNSTotal Voting Rights
30th Jul 20194:44 pmRNSHolding(s) in Company
9th Jul 20197:00 amRNSNotice of Results
1st Jul 201910:20 amRNSTotal Voting Rights
24th Jun 20194:05 pmRNSHolding(s) in Company
31st May 20193:13 pmRNSHolding(s) in Company
31st May 20199:33 amRNSTotal Voting Rights
22nd May 20199:23 amRNSDirector Declaration
16th May 20198:30 amRNSAdditional Listing
9th May 201910:11 amRNSAwarded £1.6bn Sellafield contract
8th May 201912:21 pmRNSResult of AGM
8th May 20197:00 amRNSAGM Trading Update
1st May 201912:26 pmRNSTotal Voting Rights
23rd Apr 201912:05 pmRNSBlock listing Interim Review
1st Apr 201910:03 amRNSTotal Voting Rights
22nd Mar 20197:00 amRNSMorgan Sindall Group announces £1bn joint venture
21st Mar 201911:38 amRNSAnnual Financial Report
14th Mar 20193:36 pmRNSAdditional Listing - Amendment
14th Mar 20198:00 amRNSAdditional Listing
5th Mar 20194:03 pmRNSHolding(s) in Company
4th Mar 20193:19 pmRNSDirector/PDMR Shareholding
4th Mar 20193:13 pmRNSDirector/PDMR Shareholding
4th Mar 20193:10 pmRNSDirector/PDMR Shareholding
1st Mar 20191:58 pmRNSTotal Voting Rights
21st Feb 20197:00 amRNSFinal Results
1st Feb 201910:28 amRNSTotal Voting Rights
10th Jan 20193:37 pmRNSHolding(s) in Company
9th Jan 20197:00 amRNSNotice of Results
3rd Jan 20192:04 pmRNSTotal Voting Rights
19th Dec 201810:54 amRNSDirector Declaration
3rd Dec 20184:37 pmRNSTotal Voting Rights
20th Nov 20187:00 amRNSSenior Management Forum
16th Nov 20182:53 pmRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSTrading Update
29th Oct 201811:30 amRNSNotice of Trading Update
22nd Oct 20189:01 amRNSBlock listing Interim Review
9th Oct 20184:08 pmRNSHolding(s) in Company
1st Oct 201810:08 amRNSTotal Voting Rights
28th Sep 20183:47 pmRNSHolding(s) in Company
27th Sep 20188:00 amRNSDirectorate Change
24th Sep 20188:18 amRNSHolding(s) in Company
4th Sep 20184:15 pmRNSHolding(s) in Company
3rd Sep 201812:02 pmRNSHolding(s) in Company
3rd Sep 20189:25 amRNSTotal Voting Rights
14th Aug 20187:00 amRNSDirectorate Change
8th Aug 20187:00 amRNSHalf-year Report
3rd Aug 20183:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.